UV-light induces p38 MAPK-dependent phosphorylation of Bcl10

Biochemical and Biophysical Research Communications

Volumn 301, Issue 4, 2003, Pages 923-926

  Bodero, Amanda J ^a   Ye, Ruiqiong ^b   Lees Miller, Susan P ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b NONE

Author keywords

Bcl10; p38; PD169316; Phosphorylation; SB203580; Stress activated protein kinase; UV

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 NITROPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN BCL 10; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; LIGHT; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; ULTRAVIOLET IRRADIATION; ULTRAVIOLET RADIATION;

EID: 0037459084     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00063-9     Document Type: Article

References (22)

1. Willis T.G., Jadayel D.M., Du M.Q., Peng H., Perry A.R., Abdul-Rauf M., Price H., Karran L., Majekodunmi O., Wlodarska I., Pan L., Crook T., Hamoudi R., Isaacson P.G., Dyer M.J. Bcl10 is involved int(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell. 96:1999;35-45.
2. Thome M., Tschopp J. Bcl10. Curr. Biol. 12:2002;R45.
3. Bertin J., Guo Y., Wang L., Srinivasula S.M., Jacobson M.D., Poyet J.L., Merriam S., Du M.Q., Dyer M.J., Robison K.E., DiStefano P.S., Alnemri E.S. CARD9 is a novel caspase recruitment domain-containing protein that interacts with BCL10/CLAP and activates NF-κB. J. Biol. Chem. 275:2000;41082-41086.
4. Bertin J., Wang L., Guo Y., Jacobson M.D., Poyet J.L., Srinivasula S.M., Merriam S., DiStefano P.S., Alnemri E.S. CARD11 and CARD14 are novel caspase recruitment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family members that interact with Bcl10 andactivate NF-κB. J. Biol. Chem. 276:2001;11877-11882.
5. McAllister-Lucas L.M., Inohara N., Lucas P.C., Ruland J., Benito A., Li Q., Chen S., Chen F.F., Yamaoka S., Verma Nunez I.M., Mak T.W., Nunez G. Bimp1, a MAGUK family member linking protein kinase Cactivation to Bcl10-mediated NF-κB induction. J. Biol. Chem. 276:2001;30589-30597.
6. Ruland J., Duncan G.S., Elia A., del Barco Barrantes I., Nguyen L., Plyte S., Millar D.G., Bouchard D., Wakeham A., Ohashi P.S., Mak T.W. Bcl10 is a positive regulator of antigen receptor-induced activation of NF-κB and neural tube closure. Cell. 104:2001;33-42.
7. Karin M., Lin A. NF-κB at the crossroads of life and death. Nat. Immunol. 3:2002;221-227.
8. Li N., Banin S., Ouyang H., Li G.C., Courtois G., Shiloh Y., Karin M., Rotman G. ATM is required for IκB kinase (IκK) activation in response to DNA double strand breaks. J. Biol. Chem. 276:2001;8898-8903.
9. Li N., Karin M. Ionizing radiation and short wavelength UV activate NF-κB through two distinct mechanisms. Proc. Natl. Acad. Sci. USA. 95:1998;13012-13017.
10. Li N., Karin M. Is NF-κB the sensor of oxidative stress? FASEB J. 13:1999;1137-1143.
11. Kyriakis J.M., Avruch J. Mammalian mitogen-activated proteinkinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81:2001;807-869.
12. Yui D., Yoneda T., Oono K., Katayama T., Imaizumi K., Tohyama M. Interchangeable binding of Bcl10 to TRAF2 and cIAPs regulates apoptosis signaling. Oncogene. 20:2001;4317-4323.
13. Gaide O., Martinon F., Micheau O., Bonnet D., Thome M., Tschopp J. Carma1, a CARD-containing binding partner of Bcl10, induces Bcl10 phosphorylation and NFκB activation. FEBS Lett. 496:2001;121-127.
14. Allalunis-Turner M.J., Zia P.K., Barron G.M., Mirzayans R., Day III R.S. Radiation-induced DNA damage and repair in cells of a radiosensitive human malignant glioma cell line. Radiat. Res. 144:1995;288-293.
15. Lees-Miller S.P., Sakaguchi K., Ullrich S.J., Appella E., Anderson C.W. Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53. Mol. Cell. Biol. 12:1992;5041-5049.
16. Allalunis-Turner M.J., Lintott L.G., Barron G.M., Day III R.S., Lees-Miller S.P. Lack of correlation between DNA-dependent protein kinase activity and tumor cell radiosensitivity. Cancer Res. 55:1995;5200-5202.
17. Cohen P. Protein kinases - the major drug targets of the twenty-first century? Nat. Rev. Drug Discov. 1:2002;309-315.
18. Alessi D.R., Cuenda A., Cohen P., Dudley D.T., Saltiel A.R. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:1995;27489-27494.
19. Cuenda A., Rouse J., Doza Y.N., Meier R., Cohen P., Gallagher T.F., Young P.R., Lee J.C. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364:1995;229-233.
20. Gallagher T.F., Seibel G.L., Kassis S., Laydon J.T., Blumenthal M.J., Lee J.C., Lee D., Boehm J.C., Fier-Thompson S.M., Abt J.W., Soreson M.E., Smietana J.M., Hall R.F., Garigipati R.S., Bender P.E., Erhard K.F., Krog A.J., Hofmann G.A., Sheldrake P.L., McDonnell P.C., Kumar S., Young P.R., Adams J.L. Regulation of stress-induced cytokine production by pyridinylimidazoles; inhibition of CSBP kinase. Bioorg. Med. Chem. 5:1997;49-64.
21. Davies S.P., Reddy H., Caivano M., Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351:2000;95-105.
22. English J.M., Cobb M.H. Pharmacological inhibitors of MAPK pathways. Trends Pharmacol. Sci. 23:2002;40-45.